Also known as: Invirase API; Saquinavir Mesylate
Saquinavir is a first-generation HIV protease inhibitor and active pharmaceutical ingredient used as part of combination antiretroviral therapy (ART) for HIV-1 infection. Mediocon Inc supplies high-purity Saquinavir API conforming to BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.
Saquinavir inhibits the HIV-1 protease enzyme, preventing viral polyprotein processing and thus the maturation of infectious HIV particles. It is used in combination with ritonavir (as a pharmacokinetic booster) in antiretroviral regimens.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Saquinavir (CAS 149845-06-7) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Saquinavir is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance